Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

5 Important Considerations for EMS Naloxone Administration

By Eric J. Cortez, MD, FAEMS; and John R. Casey, DO, MA, FACEP | on September 12, 2017 | 0 Comment
Uncategorized
  • Tweet
  • Email
Print-Friendly Version

1) Endpoints of Therapy: More is Not Always Better

EMS providers may encounter patients with complete or partial opiate toxidromes, with multiple drug exposures, or at various stages of overdose. This variability is important to consider when discussing endpoints of naloxone therapy.

You Might Also Like
  • Opinion: Prehospital Naloxone Administration Is Safe
  • Naloxone Distribution to Patients in Emergency Department Raises Controversy
  • Georgia Joins Ranks of States Supporting Naloxone Use in Overdose Cases

Apnea management with bag valve mask ventilation and opiate reversal is the sine qua non of naloxone administration. Increased opiate potency with the addition of fentanyl adulterants can substantially increase the amount of naloxone required for apnea reversal. In one EMS study, the percentage of patients receiving multiple doses of naloxone increased from 14.5 percent in 2012 to 18.2 percent in 2015.1 Recent reports have found that 20 mg of naloxone may be needed to reverse profound overdose effects.

When patients present with complete opiate toxidromes (syndromes caused by dangerous levels of toxins in the body) and EMS providers have a high index of suspicion for opiate-induced apnea (such as apnea with pinpoint pupils), the use of multiple naloxone doses may be a legitimate strategy. In contrast, the use of multiple naloxone doses to reverse opiate-induced altered mental status and completely wake the patient may be harmful, especially when it is associated with anchoring bias. While partial response to an initial dose may indicate the need for additional naloxone, partial responses may also suggest the presence of an alternative etiology or a mixed presentation. The use of large naloxone doses in the setting of partial toxidromes, multiple drug exposures or diagnostic uncertainty may harm the patient and compromise EMS provider safety by inducing agitation, exacerbating other co-existing diseases, and delaying recognition of other emergencies.

2) Adverse Effects of Acute Withdrawal: They Can Be Serious

Rapid opiate reversal with naloxone may induce acute opiate withdrawal and precipitate severe cardiovascular, neurological, and behavioral emergencies. Lameijer et al described a case of ventricular tachycardia following naloxone administration and suggest that patients with mixed presentations or exposure to large opiate doses are more prone to developing ventricular tachycardia or ventricular fibrillation.2 When acute withdrawal is induced in the setting of chronic opiate overdose with acute toxicity of non-opiate drugs or an acute medical emergency, the withdrawal state may exacerbate the toxicity or medical emergency. A slower, more cautious approach using smaller aliquots of naloxone may be more appropriate.

3) EMS Provider and Patient Safety: Avoid Chasing Your Tail

Patients may experience severe agitation following naloxone administration, which is concerning for two reasons. First, sedation may be needed to calm the patient, but may also result in hypotension, respiratory depression, or cardiac dysrhythmias. Second, agitation may compromise EMS provider safety, especially if escalation occurs during transport in the absence of law enforcement.

4) Refusal of Transport: Not All Overdose Reversals Are Straightforward

Patient refusal of transport may occur following naloxone administration if decision-making capacity has been restored. Non-transports following prehospital naloxone administration are considered relatively safe.3,4 However, since these studies, the strength and duration of action of abused substances has changed significantly. These characteristics should be accounted for when determining decision-making capacity. While most non-transports will continue to be safe, EMS providers must diligently exclude other etiologies and ensure the patient has appropriate medical decision making capacity.

5) Delayed Diagnosis and Treatment: Remember the ABCs

A final and significant potential negative consequence of multiple naloxone doses is delayed recognition and treatment of acute medical and traumatic emergencies. Hypoglycemia, severe sepsis, anaphylaxis, stroke, intracranial hemorrhage, and encephalopathy can all mimic an opioid overdose. Anchoring bias may lead to failure to diagnosis and treat alternative etiologies. Ongoing assessment of the airway to relieve or prevent airway obstruction is essential. In most cases, effective bag valve mask ventilation should take place on arrival of first responders (ie, police, fire, and EMS) and as additional doses of naloxone are prepared and administered.

Conclusion

EMS use of naloxone in opiate overdoses can be lifesaving, and in the majority of cases, the risk of iatrogenic harm is exceedingly low. However, overdoses are becoming more complex and the potential harms of multiple naloxone doses should be considered before administration.

References

  1. Faul M, Lurie P, Kinsman JM, et al. Multiple naloxone administrations among emergency medical service providers is increasing. Prehosp Emerg Care. 2017;21(4):411-419.
  2. Lemeijer J, Azizi N, Ligtenberg JJ, et al. Ventricular tachycardia after naloxone administration: a drug related complication? Case report and literature review. Drug Saf Case Rep. 2014;1(1):2.
  3. Wampler DA, Molina DK, McManus J, et al. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011;15(3):320-324.
  4. Willman MW, Liss DB, Schwarz ES, et al. Do heroin overdose patients require observation after receiving naloxone? Clin Toxicol (Phila). 2017;55(2):81-87.


Dr. Cortez is OhioHealth System associate EMS medical director at OhioHealth Doctors Hospital, clinical assistant professor of emergency medicine, and associate medical director of the Columbus Division of Fire. Dr. Casey is OhioHealth Doctors Hospital emergency medicine associate residency director, clinical assistant professor of emergency medicine, and EMS director for Springfield Regional Medical Center.

Pages: 1 2 | Multi-Page

Topics: AddictionNaloxoneOpioidOverdose

Related

  • The New Mexico Bridge Program

    March 5, 2023 - 0 Comment
  • Dr. Alister Martin’s Medical Entrepreneurship for Equity

    February 10, 2023 - 0 Comment
  • Shift from Metabolize-to-Freedom to Medication-Assisted Treatment

    February 7, 2023 - 0 Comment

Current Issue

ACEP Now May 03

Read More

No Responses to “5 Important Considerations for EMS Naloxone Administration”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603